Medifast Inc (MED)
Medifast Inc brought in $316.9M of revenue over the twelve months to June 30, 2026, down 34.0% from a year earlier. It posted a net loss of $25.6M. Operating cash flow minus capital spending left $1.2M of free cash flow in fiscal 2025. At June 30, 2026 it held $71.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 3, 2026.
What Medifast Inc does
Medifast Inc is registered with the SEC under industry code SIC 2090 (Miscellaneous Food Preparations & Kindred Products). Its shares trade on NYSE under the ticker MED.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $385.8M | -$18.7M | -$1.70 | $1.2M |
| 2024 | $602.5M | $2.1M | $0.19 | $17M |
| 2023 | $1.1B | $99.4M | $9.10 | $141.2M |
| 2022 | $1.6B | $143.6M | $12.73 | $177.9M |
| 2021 | $1.5B | $164M | $13.89 | $60.3M |
| 2020 | $934.8M | $102.9M | $8.68 | $139.3M |
Latest SEC filings
What Medifast Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 21, 2026Activist stake changed SCHEDULE 13D/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- August 3, 2026
- August 3, 2026Quarterly report 10-Q · period to June 30, 2026
- August 3, 2026
- July 29, 2026Passive stake changed SCHEDULE 13G/A
- July 17, 2026
- June 1, 2026
Questions about MED
What does Medifast Inc do?
Medifast Inc is registered with the SEC under industry code SIC 2090 (Miscellaneous Food Preparations & Kindred Products). Its shares trade on NYSE under the ticker MED.
Is Medifast Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $25.6M on revenue of $316.9M.
How much revenue does Medifast Inc make?
Over the twelve months to June 30, 2026 Medifast Inc reported revenue of $316.9M. That is 34.0% less than a year earlier.
When did Medifast Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 3, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 28, 2026.
Similar companies
Follow MED
Get an email when Medifast Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow MED: get an email when it filesWhere the numbers come from
Financial figures are the values Medifast Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.